Beersheba, Israel

Shifra Katz

This inventor holds 1 USPTO granted patent. Top assignee: Agis Industries Ltd.. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shifra Katz: Innovator in Pharmaceutical Compositions

Introduction

Shifra Katz is a prominent inventor based in Beer-Sheva, Israel. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative work on mupirocin compositions. Her dedication to research and development has led to the creation of a patented formulation that enhances the stability and effectiveness of mupirocin.

Latest Patents

Shifra Katz holds 1 patent for her invention titled "Pharmaceutical compositions containing mupirocin." This invention provides a chemically stable composition that includes a therapeutically effective amount of mupirocin, combined with a carrier selected from oleyl alcohol, castor oil, or a mixture thereof. The composition may also include a pharmaceutically acceptable base, which further enhances its utility in medical applications.

Career Highlights

Katz is associated with Agis Industries Ltd., a company known for its commitment to developing high-quality pharmaceutical products. Her work at Agis Industries has allowed her to focus on innovative solutions that address various medical needs.

Collaborations

Shifra collaborates with talented professionals in her field, including Ilana Lavon and Chalil Abu-Gnim. These partnerships foster a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Shifra Katz's contributions to pharmaceutical compositions demonstrate her innovative spirit and commitment to improving healthcare solutions. Her work continues to impact the industry positively, showcasing the importance of research and collaboration in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…